meglumine has been researched along with Bladder Cancer in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, A; King, BF; Niederhauser, BD; Takahashi, N | 1 |
| Bass, P; Birch, BR; Cooper, AJ; Crook, TJ; Dyer, JP; Harris, NM; Solomon, LZ | 1 |
| Anderson, WR; Birch, BR; Cooper, AJ; Harris, NM; Lwaleed, BA; Solomon, LZ | 1 |
| Cotton, F; Gilly, FN; Glehen, O; Granier, A; Pellet, O; Sournac, L | 1 |
| Cooper, AJ; Harris, NM; Lwaleed, BA; Mackie, SJ; Sharma, DM | 1 |
| Ascher, SM; Carroll, PR; Chalpin, DB; Hricak, H; Kim, B; Semelka, RC | 1 |
| Fujita, M; Hosomi, N; Inoue, E; Kadota, T; Kotake, T; Kuriyama, K; Kuroda, C; Kuroda, M; Narumi, Y; Sawai, Y | 1 |
| Barentsz, JO; Jager, GJ; Karssemeijer, N; Peters, H; Ruijs, SH; Strijk, SP; van Vierzen, PB; Witjes, JA | 1 |
| Allkemper, T; Heindel, W; Tombach, B | 1 |
| Birch, BR; Cooper, AJ; Crook, TJ; Dyer, JP; McCormick, RI | 1 |
| Hiramatsu, K; Imai, Y; Izutsu, M; Tachibana, M; Tanimoto, A; Tazaki, H; Yuasa, Y | 1 |
1 trial(s) available for meglumine and Bladder Cancer
| Article | Year |
|---|---|
Intravesical meglumine gamma-linolenic acid in superficial bladder cancer: an efficacy study.
Topics: Administration, Intravesical; Adult; Carcinoma, Transitional Cell; Drug Combinations; Female; gamma-Linolenic Acid; Humans; Male; Meglumine; Treatment Outcome; Urinary Bladder Neoplasms | 2002 |
10 other study(ies) available for meglumine and Bladder Cancer
| Article | Year |
|---|---|
Utility of gadolinium-enhanced MR urography in detection of bladder carcinoma.
Topics: Aged; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Urinary Bladder Neoplasms; Urography | 2013 |
Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cell Division; Drug Synergism; Epirubicin; Flow Cytometry; gamma-Linolenic Acid; Humans; Meglumine; Microscopy, Confocal; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2003 |
MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis.
Topics: Carcinoma; Contrast Media; Gadolinium; Humans; Intestinal Neoplasms; Intestines; Magnetic Resonance Imaging; Meglumine; Mesentery; Organometallic Compounds; Peritoneal Neoplasms; Urinary Bladder; Urinary Bladder Neoplasms | 2006 |
Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Eicosapentaenoic Acid; Epirubicin; Fatty Acids, Omega-3; Humans; Meglumine; Mitomycin; Urinary Bladder Neoplasms | 2006 |
Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
Topics: Carcinoma, Transitional Cell; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms | 1994 |
Bladder tumors: staging with gadolinium-enhanced oblique MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Models, Structural; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Urinary Bladder; Urinary Bladder Neoplasms | 1993 |
Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging.
Topics: Biopsy; Carcinoma, Transitional Cell; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Sensitivity and Specificity; Urinary Bladder; Urinary Bladder Neoplasms | 1996 |
[Gd-BOPTA enhanced excretory MR urography without administration of diuretics].
Topics: Adult; Diuretics; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Pelvic Neoplasms; Reproducibility of Results; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urography; Urologic Neoplasms | 2001 |
The effects of meglumine gamma linolenic acid (MeGLA) on an organ culture model of superficial bladder cancer.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Humans; Meglumine; Neoplasms, Experimental; Organ Culture Techniques; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 2002 |
Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pentetic Acid; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 1992 |